Arcus Biosciences (RCUS)
NYSE • RCUS • US03969F1093
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 29, 2026, ORTEX estimated 11.5% of free float sold short, 4.8 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
Market Cap
2.51b USD | # 3527 in US
Volume
1.84m shares | 44.65m USD
Shares Outstanding
143.99m
Free Float Shares
74.44% | 107.18m
